OTCPK:CRXWQ (USA)
Â
Warrants (09/09/2026)
$
0.00
0 (0%)
09:42 AM EST
Business Description
Clarus Therapeutics Holdings Inc
NAICS : 325412
SIC : 2834
Share Class Description:
CRXWQ: Warrants (09/09/2026)Description
Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company is focused on focused on the commercialization of JATENZO (testosterone undecanoate), the first and only oral testosterone replacement, or testosterone replacement therapy, and JATENZO is the sole source of company's revenue.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.47 | |||||
| Equity-to-Asset | -0.27 | |||||
| Debt-to-Equity | -3.1 | |||||
| Debt-to-EBITDA | -1.82 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -11.41 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.79 | |||||
| Quick Ratio | 0.52 | |||||
| Cash Ratio | 0.31 | |||||
| Days Inventory | 1471.61 | |||||
| Days Sales Outstanding | 161.8 | |||||
| Days Payable | 1318.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 446.12 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.57 | |||||
| Operating Margin % | -235.99 | |||||
| Net Margin % | -193 | |||||
| ROA % | -71.53 | |||||
| ROIC % | -90.92 | |||||
| ROC (Joel Greenblatt) % | -881.97 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.96 | |||||
| EV-to-EBITDA | -0.96 | |||||
| EV-to-Revenue | 1.27 | |||||
| EV-to-FCF | -0.38 | |||||
| Earnings Yield (Greenblatt) % | -104.17 | |||||
| FCF Yield % | -77582.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CRXWQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clarus Therapeutics Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 1.17 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clarus Therapeutics Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clarus Therapeutics Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clarus Therapeutics Holdings Inc Frequently Asked Questions
What is Clarus Therapeutics Holdings Inc(CRXWQ)'s stock price today?
The current price of CRXWQ is $0.00. The 52 week high of CRXWQ is $1.17 and 52 week low is $0.00.
When is next earnings date of Clarus Therapeutics Holdings Inc(CRXWQ)?
The next earnings date of Clarus Therapeutics Holdings Inc(CRXWQ) is .
Does Clarus Therapeutics Holdings Inc(CRXWQ) pay dividends? If so, how much?
Clarus Therapeutics Holdings Inc(CRXWQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers